BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17825088)

  • 1. Direct effects of the angiotensin-converting enzyme inhibitor ramiprilat on adult rat ventricular cardiomyocytes.
    Helmig S; Schuckenböhmer P; Heger J; Euler G; Piper HM; Schlüter KD
    Acta Physiol (Oxf); 2007 Dec; 191(4):267-74. PubMed ID: 17825088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
    Hartman JC
    Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of angiotensin-converting enzyme reduces rat liver reperfusion injury via bradykinin-2-receptor.
    Freise H; Palmes D; Spiegel HU
    J Surg Res; 2006 Aug; 134(2):231-7. PubMed ID: 16513137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme is involved in outside-in signaling in endothelial cells.
    Kohlstedt K; Brandes RP; Müller-Esterl W; Busse R; Fleming I
    Circ Res; 2004 Jan; 94(1):60-7. PubMed ID: 14615289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE inhibitor potentiation of bradykinin-induced venoconstriction.
    Hecker M; Blaukat A; Bara AT; Müller-Esterl W; Busse R
    Br J Pharmacol; 1997 Aug; 121(7):1475-81. PubMed ID: 9257930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro interactions between ramiprilat and angiotensin I-converting enzyme in endothelial cells.
    Baudin B; Drouet L
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S37-42. PubMed ID: 2483427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid hormone improves contractile performance of adult rat ventricular cardiomyocytes at low concentrations in a non-acute way.
    Tastan I; Schreckenberg R; Mufti S; Abdallah Y; Piper HM; Schlüter KD
    Cardiovasc Res; 2009 Apr; 82(1):77-83. PubMed ID: 19168854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.
    Schmeisser A; Soehnlein O; Illmer T; Lorenz HM; Eskafi S; Roerick O; Gabler C; Strasser R; Daniel WG; Garlichs CD
    Biochem Biophys Res Commun; 2004 Dec; 325(2):532-40. PubMed ID: 15530425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined renin-angiotensin system blockade and dietary sodium restriction impairs cardiomyocyte contractility.
    Trongtorsak P; Morgan TO; Delbridge LM
    J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):213-9. PubMed ID: 14689368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling via the angiotensin-converting enzyme enhances the expression of cyclooxygenase-2 in endothelial cells.
    Kohlstedt K; Busse R; Fleming I
    Hypertension; 2005 Jan; 45(1):126-32. PubMed ID: 15569856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone-related peptide improves contractile responsiveness of adult rat cardiomyocytes with depressed cell function irrespectively of oxidative inhibition.
    Lütteke D; Ross G; Abdallah Y; Schäfer C; Piper HM; Schlüter KD
    Basic Res Cardiol; 2005 Jul; 100(4):320-7. PubMed ID: 15944810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of central injection of angiotensin-converting-enzyme inhibitor and angiotensin type 1 receptor antagonist on the brain NF-kappaB and AP-1 activities of rats given LPS.
    Watanabe K; Taniguchi M; Miyoshi M; Shimizu H; Imoto T; Sato K; Watanabe T
    Peptides; 2006 Jun; 27(6):1538-46. PubMed ID: 16356591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
    Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ACE inhibition: mechanisms of "cardioprotection" in acute myocardial ischemia].
    Schölkens BA; Linz W
    Klin Wochenschr; 1991; 69 Suppl 24():1-5. PubMed ID: 1865630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE inhibition lowers angiotensin-II-induced monocyte adhesion to HUVEC by reduction of p65 translocation and AT 1 expression.
    Soehnlein O; Schmeisser A; Cicha I; Reiss C; Ulbrich H; Lindbom L; Daniel WG; Garlichs CD
    J Vasc Res; 2005; 42(5):399-407. PubMed ID: 16088213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta1 improves cardiac performance via up-regulation of laminin receptor 37/67 in adult ventricular cardiomyocytes.
    Wenzel S; Henning K; Habbig A; Forst S; Schreckenberg R; Heger J; Maxeiner H; Schlüter KD
    Basic Res Cardiol; 2010 Sep; 105(5):621-9. PubMed ID: 20556404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The possible role of bradykinin in the antiischemic activity of ACE-inhibitors.
    Martorana PA; Schölkens BA
    Agents Actions Suppl; 1992; 38 ( Pt 3)():98-102. PubMed ID: 1462888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitor ramiprilat interferes with the sequestration of the B2 kinin receptor within the plasma membrane of native endothelial cells.
    Benzing T; Fleming I; Blaukat A; Müller-Esterl W; Busse R
    Circulation; 1999 Apr; 99(15):2034-40. PubMed ID: 10209009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy of amlodipine and angiotensin-converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human hearts.
    Mital S; Loke KE; Slater JP; Addonizio L; Gersony WM; Hintze TH
    Am J Cardiol; 1999 Jun; 83(12A):92H-98H. PubMed ID: 10750596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme (ACE) inhibitors modulate cellular retinol-binding protein 1 and adiponectin expression in adipocytes via the ACE-dependent signaling cascade.
    Kohlstedt K; Gershome C; Trouvain C; Hofmann WK; Fichtlscherer S; Fleming I
    Mol Pharmacol; 2009 Mar; 75(3):685-92. PubMed ID: 19114589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.